ELAPRASE

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ELAPRASE contains one active pharmaceutical ingredient (API):

1 Idursulfase
UNII 5W8JGG2651 - IDURSULFASE

Idursulfase (idursulfase) is a purified form of the lysosomal enzyme iduronate-2-sulfatase, produced in a human cell line providing a human glycosylation profile, which is analogous to the naturally occurring enzyme. Elaprase is indicated for the long-term treatment of patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).

Read about Idursulfase

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ELAPRASE Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A16AB09 Idursulfase A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501121010034317
Country: CA Health Products and Food Branch Identifier(s): 02296314
Country: EE Ravimiamet Identifier(s): 1279964, 1279975, 1279986
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 06365001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 085287
Country: FR Base de données publique des médicaments Identifier(s): 63288174
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 114913
Country: HK Department of Health Drug Office Identifier(s): 57104
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6834
Country: JP 医薬品医療機器総合機構 Identifier(s): 3959413A1029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1027962, 1027963, 1027964
Country: NL Z-Index G-Standaard, PRK Identifier(s): 130788
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 13423
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100042188
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68717001, W68717002, W68717003
Country: SG Health Sciences Authority Identifier(s): 13902P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699943790028
Country: US FDA, National Drug Code Identifier(s): 54092-700
Country: ZA Health Products Regulatory Authority Identifier(s): 45/31/0333

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.